Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
Recruiting now
Conditions studied: Leukemia, Acute, MDS
In brief
The purpose of this research study is to determine if frailty assessments can be used to predict how well patients aged 60 years and older will do after chemotherapy, CAR T-cell therapy, or allogeneic stem cell transplant.
Key facts
- Study ID
- NCT03680677
- Run by
- Abramson Cancer Center at Penn Medicine
- People needed
- 20
- Starts
- 2018-09-21
- Expected to finish
- 2026-11-01
- Last updated by the study team
- 2025-07-31
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.